Eriksson L S, Söderman C, Ericzon B G, Eleborg L, Wahren J, Hedenstierna G
Department of Internal Medicine, Huddinge University Hospital, Karolinska Institute, Sweden.
Hepatology. 1990 Dec;12(6):1350-7. doi: 10.1002/hep.1840120616.
To examine the effect of liver transplantation on the respiratory and cardiovascular functions, ventilation/perfusion relationships were determined by multiple inert gas elimination technique in six patients with end-stage liver disease 1 to 19 mo before and 2 to 6 mo after liver transplantation. Cardiac output and pulmonary vascular pressures were measured after catheterization of the pulmonary artery. All patients had normal spirometry and chest x-ray films before transplantation. PaO2 before transplantation was 78.8 +/- 7.4 mm Hg (range = 51.8 to 102.8 mm Hg). All patients had perfusion of poorly ventilated lung regions (low ventilation/perfusion relationships) varying from 3% to 19% of cardiac output (mean = 8.5% +/- 2.4% of cardiac output) and two patients had intrapulmonary shunting (3% and 20% of cardiac output). Measured and calculated PaO2 agreed closely, indicating absence of pulmonary diffusion abnormality, as well as of extrapulmonary shunting. After transplantation, PaO2 normalized in all patients, and both shunting and low ventilation/perfusion relationships disappeared. Cardiac output decreased from 9.1 +/- 1.4 to 6.6 +/- 0.5 L/min (p less than 0.05), and the pulmonary vascular resistance increased from 0.69 +/- 0.14 to 1.64 +/- 0.43 mm Hg/L/min (p less than 0.05). The systemic vascular resistance also increased (before = 8.7 +/- 1.0; after = 15.3 +/- 1.1 mm Hg/L/min; p less than 0.001). Normalization of respiratory and cardiovascular alterations, after liver transplantation, in patients with end-stage liver disease indicates that these changes have a direct functional relationship to the diseased liver. It is hypothesized that this is part of a "hepatopulmonary syndrome,' which in similarity to the hepatorenal syndrome disappears with improved liver function.
为研究肝移植对呼吸和心血管功能的影响,采用多种惰性气体清除技术,对6例终末期肝病患者在肝移植前1至19个月及移植后2至6个月测定通气/灌注关系。通过肺动脉插管测量心输出量和肺血管压力。所有患者移植前肺功能测定和胸部X光片均正常。移植前动脉血氧分压(PaO2)为78.8±7.4毫米汞柱(范围为51.8至102.8毫米汞柱)。所有患者均存在通气不良肺区域的灌注(低通气/灌注关系),占心输出量的3%至19%(平均为心输出量的8.5%±2.4%),2例患者存在肺内分流(分别为心输出量的3%和20%)。实测和计算的PaO2密切相符,表明不存在肺弥散异常以及肺外分流。移植后,所有患者的PaO2恢复正常,分流和低通气/灌注关系均消失。心输出量从9.1±1.4降至6.6±0.5升/分钟(p<0.05),肺血管阻力从0.69±0.14增至1.64±0.43毫米汞柱/升/分钟(p<0.05)。全身血管阻力也增加(移植前=8.7±1.0;移植后=15.3±1.1毫米汞柱/升/分钟;p<0.001)。终末期肝病患者肝移植后呼吸和心血管改变恢复正常,表明这些变化与患病肝脏存在直接功能关系。据推测,这是“肝肺综合征”的一部分,与肝肾综合征类似,随着肝功能改善而消失。